Pila Pharma: Tox-studies initiated

Redeye leaves its comments on Pila Pharma following today’s uplifting news that the three-month preclinical toxicological studies have been initiated.


Filip Einarsson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.